Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · Real-Time Price · USD
3.260
-0.025 (-0.76%)
At close: Mar 9, 2026, 4:00 PM EDT
3.430
+0.170 (5.21%)
After-hours: Mar 9, 2026, 5:36 PM EDT
Oramed Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Aug '21 Aug 31, 2021 |
| Market Capitalization | 130 | 98 | 93 | 471 | 544 | 640 | |
| Market Cap Growth | 44.98% | 4.69% | -80.20% | -13.48% | -15.00% | 479.35% | |
| Enterprise Value | -4 | -46 | -9 | 311 | 444 | 565 | |
| Last Close Price | 3.26 | 2.26 | 2.15 | 11.21 | 13.31 | 18.35 | |
| PE Ratio | 3.17 | - | 16.87 | - | - | - | |
| PS Ratio | 64.88 | - | 69.54 | 174.08 | 200.54 | 236.73 | |
| PB Ratio | 0.65 | 0.67 | 0.57 | 3.11 | 3.26 | 5.49 | |
| P/TBV Ratio | 0.64 | 0.67 | 0.57 | 3.10 | 3.27 | 5.53 | |
| EV/Sales Ratio | - | - | - | 115.15 | 163.83 | 208.87 | |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.32 | 0.01 | 0.00 | 0.01 | |
| Net Debt / Equity Ratio | -0.66 | -0.97 | -0.69 | -1.02 | -0.90 | -0.86 | |
| Net Debt / EBITDA Ratio | 10.38 | 11.25 | 7.21 | 3.82 | 4.05 | 4.15 | |
| Net Debt / FCF Ratio | 12.62 | 16.79 | 10.64 | 5.45 | 4.48 | 4.65 | |
| Asset Turnover | 0.01 | - | 0.01 | 0.02 | - | 0.03 | |
| Quick Ratio | 22.08 | 24.97 | 3.05 | 27.10 | 19.85 | 14.10 | |
| Current Ratio | 22.25 | 25.19 | 3.06 | 27.34 | 20.08 | 14.27 | |
| Return on Equity (ROE) | 24.48% | -12.39% | 3.24% | -23.77% | - | -30.78% | |
| Return on Assets (ROA) | -4.22% | -4.25% | -5.16% | -14.95% | - | -17.54% | |
| Return on Capital Employed (ROCE) | -6.10% | -8.50% | -9.40% | -26.00% | -21.70% | -20.00% | |
| Earnings Yield | 33.80% | -19.54% | 5.93% | -7.77% | -6.44% | -3.48% | |
| FCF Yield | -8.18% | -8.64% | -11.32% | -6.04% | -6.14% | -3.37% | |
| Buyback Yield / Dilution | -3.29% | -0.65% | -4.02% | -5.08% | -30.36% | -16.71% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.